Uncovr
Builds AI software that helps surgeons create operative reports after operations, reducing reliance on memory hours after procedures.
Overview
Uncovr is developing AI software for surgical documentation, focused on operative reports that surgeons often write from memory after procedures. The company targets hospitals, surgical teams, and clinicians seeking to streamline post-operative reporting workflows. Its stated differentiator is addressing the delay and recall burden in operative note creation, using AI to support a process that remains manual in many clinical settings. Uncovr has raised $7 million in an undisclosed round led by Index Ventures.
Funding History
Surgeons still write operative reports from memory, hours after the operation. Uncovr raised $7M, led by Index Ventures, to fix that
Frequently Asked Questions
- How much funding does AI Funding track for Uncovr?
- AI Funding tracks $7M for Uncovr across 1 funding round in this database.
- Who are Uncovr's investors?
- Uncovr's investors include Index Ventures, Seedcamp, Entrepreneurs First, Frst, No Label Ventures, and 3 others.
- What does Uncovr do?
- Uncovr is developing AI software for surgical documentation, focused on operative reports that surgeons often write from memory after procedures. The company targets hospitals, surgical teams, and clinicians seeking to streamline post-operative reporting workflows. Its stated differentiator is addressing the delay and recall burden in operative note creation, using AI to support a process that remains manual in many clinical settings. Uncovr has raised $7 million in an undisclosed round led by Index Ventures.
- Where is Uncovr headquartered?
- Uncovr is headquartered in San Francisco, CA.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.